DEC-NET Serial number GB279 |
|
Published online | 07/07/2004 14.46.00 |
Last updated | 02/08/2005 14.06.13 |
| |
Other protocol ID number | N0264130004 |
This trial has been approved by an ethics committee |
Current trial status | Open (actively recruiting new participants) |
First subject enrolment Target N. of subjects |
05/2003 N/A |
Major Disease (ICD9 class) | ESOPHAGEAL REFLUX |
Experimental drug |
DOMPERIDONE
Treatment regimen (dosage and duration) N/A |
Omeprazole
Treatment regimen (dosage and duration) N/A |
Gender | Both |
Age (range) | <16 years |
Eligibility criteria |
Inclusion criteria |
Children under 16 with a reflux index >1 |
Exclusion criteria |
Informed consent not given |
Trial design/methodology |
Phase | 3 |
Kind of study | Efficacy
|
Design | Controlled Randomised Blinded Double blind
|
Purpose of study |
To document the efficacy of domperidone and/or omeprazole in neurologically normal and abnormal children found to have significant GOR on oesophageal pH monitoring |
|
|
|
|
Summary of study design, objectives, and ongoing research findings |
Double blind placebo controlled prospective randomised controlled trial. Randomised to A]domperidone B]omeprazole C]combination of both.
The aim of the study is to document the efficacy of domperidone and/or omeprazole in neurologically normal and abnormal children found to have significant GOR on oesophageal pH monitoring |